Dashboard
Manage Tickers

EIGRQEiger BioPharmaceuticals Inc


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 8
-- x --
-- x --
-- - --
$ 1.61 - $ 16.00
373
na
na
$ 3.08
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-small-cap-amylyx-pharmaceuticals-stock-trading-higher-on-wednesday
Why Is Small Cap Amylyx Pharmaceuticals St...
07/10/2024 19:32:36

Amylyx Pharmaceuticals acquired avexitide from Eiger BioPharmaceuticals Inc. for $35.1 million. Avexitide, a GLP-1 receptor ant...

Core News & Articles
Amylyx Pharmaceuticals Acquired Avexitide ...
07/10/2024 11:04:34

As part of the transaction, Amylyx assumed certain contractual obligations from Eiger, including a 3% royalty on future sales o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION